Kostas Stamatopoulos is a specialist in Hematology, Director of the Institute of Applied Biosciences at CERTH, the Center for Research and Technology Hellas, Thessaloniki, Greece. He also holds the position of Visiting Professor at the Karolinska Institute, Stockholm, Sweden. Dr Stamatopoulos has been the Coordinator of the Hellenic Precision Medicine Network in Oncology (2018-2021). Currently, he serves as member of the Research and European Affairs Committees of the European Hematology Association; Board member of ERIC, the European Research Initiative on chronic lymphocytic leukemia; Steering Committee member of the Scientific Working Group on Precision Hematology of the European Hematology Association. His research interests include: precision medicine in cancer; immunobiology of lymphoid malignancies; and, patient empowerment in care.
Updated: January 2023